test

Andreas Halvorsen / Scott M. Hendler

@Viking Global Investors Lp

Latest period2024 - Q3ReportedManaged Assets$27.435BTotal holdings83
Assets growth rate5.45%Assets growth rate (2-Q avg)1.16%Continuous growth in asset value1 quarters

Portfolio positions

This chart displays the top 10 holdings in Viking Global Investors Lp's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 83 positions.

Assets under management

The assets under management (AUM) of Viking Global Investors Lp over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 27.435B in assets, with a quarterly growth rate of 5.45% and a 2-quarter average growth rate of 1.16%. The portfolio is managed by Andreas Halvorsen, Scott M. Hendler, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
REGNRegeneron Pharmaceuticals
Recent Activity
New Position
0.2%
$52.425M
49,870 shares@ $1051.25 avg price
ZLABZai Lab Ltd
Recent Activity
Decreased -4.29%
0.18%
$47.071M
1.95M shares@ $24.14 avg price
CVNACarvana Co
Recent Activity
Decreased -51.39%
0.18%
$46.851M
269,088 shares@ $174.12 avg price
VKTXViking Therapeutics Inc
Recent Activity
Decreased -46.69%
0.17%
$45.705M
721,926 shares@ $63.31 avg price
ORICOric Pharmaceuticals Inc
Recent Activity
0.15%
$41M
4M shares@ $10.25 avg price
EWTXEdgewise Therapeutics Inc
Recent Activity
0.15%
$39.532M
1.481M shares@ $26.7 avg price
DAWNDay One Biopharmaceuticals I
Recent Activity
0.13%
$35.641M
2.559M shares@ $13.94 avg price
DNAGinkgo Bioworks Holdings Inc
Recent Activity
New Position
0.11%
$29.154M
3.577M shares@ $8.15 avg price
INBXInhibrx Biosciences Inc
Recent Activity
0.11%
$27.995M
1.788M shares@ $15.66 avg price
TRVITrevi Therapeutics Inc
Recent Activity
0.06%
$14.696M
4.4M shares@ $3.34 avg price